[Therapy of erectile dysfunction]

Orv Hetil. 2010 Feb 28;151(9):354-7. doi: 10.1556/OH.2010.28800.
[Article in Hungarian]
No abstract available

MeSH terms

  • Adrenergic alpha-Antagonists / therapeutic use
  • Androgens / administration & dosage
  • Androgens / therapeutic use*
  • Carbolines / therapeutic use
  • Diagnosis, Differential
  • Erectile Dysfunction / diagnosis
  • Erectile Dysfunction / drug therapy
  • Erectile Dysfunction / etiology*
  • Erectile Dysfunction / psychology
  • Erectile Dysfunction / therapy*
  • Humans
  • Imidazoles / therapeutic use
  • Injections
  • Male
  • Penile Implantation
  • Penis / drug effects
  • Penis / physiopathology*
  • Phosphodiesterase Inhibitors / administration & dosage
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Piperazines / therapeutic use
  • Purines / therapeutic use
  • Sildenafil Citrate
  • Sulfones / therapeutic use
  • Tadalafil
  • Triazines / therapeutic use
  • Vacuum
  • Vardenafil Dihydrochloride
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use*

Substances

  • Adrenergic alpha-Antagonists
  • Androgens
  • Carbolines
  • Imidazoles
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Triazines
  • Vasodilator Agents
  • Vardenafil Dihydrochloride
  • Tadalafil
  • Sildenafil Citrate